| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | LIXA is focused on developing scalable antibiofilm technologies to treat antimicrobial resistance (AMR), for anyone, anything and anywhere. Our technologies disrupt both mature and immature biofilms and are compatible with most existing antimicrobials. We are open to partnerships to develop real solutions to AMR. |
| Category: | Health & biotech |
| URL: | https://www.lixa.life/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2021 |
| Address: | Level 1/22 Stirling Hwy, Nedlands WA 6009 |
| State: | Western Australia |
| Overseas Operations: | No |
| Twitter: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/lixa/ |
| Founders: | |
| Awards won: | |
